Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China · Delayed Price · Currency is CNY 15.58
+0.59 (3.94%)
Sep 5, 2025, 3:04 PM CST
Yifan Pharmaceutical Revenue
Yifan Pharmaceutical had revenue of 1.31B CNY in the quarter ending June 30, 2025, with 0.18% growth. This brings the company's revenue in the last twelve months to 5.16B, up 8.55% year-over-year. In the year 2024, Yifan Pharmaceutical had annual revenue of 5.16B with 26.84% growth.
Revenue (ttm)
5.16B
Revenue Growth
+8.55%
P/S Ratio
3.67
Revenue / Employee
1.26M
Employees
4,098
Market Cap
18.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.16B | 1.09B | 26.84% |
| Dec 31, 2023 | 4.07B | 231.47M | 6.03% |
| Jan 1, 2023 | 3.84B | -572.39M | -12.98% |
| Jan 1, 2022 | 4.41B | -991.34M | -18.36% |
| Dec 31, 2020 | 5.40B | 213.54M | 4.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Shanghai United Imaging Healthcare | 10.98B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |